Charles River to Buy WuXi PharmaTech for $1.6 Billion (Update1)

[guest]

Charles River Laboratories International Inc. agreed to buy WuXi PharmaTech (Cayman) Inc. for about $1.6 billion to expand in China, where revenue from drug-testing services is growing as much as 30 percent a year.


More...

Toggle signature
||||| Mentor Group Access Now! |||||